Table 2 Health effects of typical and atypical antipsychotic compared to 'do nothing' over the lifetime people with schizophrenia in the 2005 Thai population
From: Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia
Intervention | DALYs averted | |||
|---|---|---|---|---|
| Â | Severity of disease | Weight gain | Mortality due to suicide | Total (95% CI) |
Typicals | 450,000 | -5,800 | - | 440,000 (290,000, 610,000) |
Risperidone | 540,000 | -9,100 | - | 530,000 (370,000, 710,000) |
Olanzapine | 580,000 | -14,000 | - | 570,000 (390,000, 770,000) |
Clozapine | 620,000 | -15,000 | 20,000 | 630,000 (440,000, 830,000) |
FI+Risperidone1 | 920,000 | -9,100 | - | 910,000 (640,000, 1,100,000) |